Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_assertion type Assertion NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_head.
- NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_assertion description "[This article reviews the MDR related genes, major-vault protein (MVP), anti-apoptotic protein (Bcl-2) and the molecular mechanisms that may contribute to chemoresistance, in addition to the upregulated MDR phenotypes present in CSCs that has recently been identified in gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_provenance.
- NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_assertion evidence source_evidence_literature NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_provenance.
- NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_assertion SIO_000772 18259841 NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_provenance.
- NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_assertion wasDerivedFrom befree-2016 NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_provenance.
- NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_assertion wasGeneratedBy ECO_0000203 NP654416.RAV6ILPaZWLZe-kNeg4b13yJApp_8WMBYfTFPmK_LBPyc130_provenance.